Used primarily as an intermediate in the synthesis of platinum-based anticancer drugs. It serves as a key precursor in the preparation of chemotherapeutic agents due to its ability to form stable complexes that interact with DNA, leading to cell cycle inhibition and apoptosis in tumor cells. Commonly employed in research settings for developing new platinum derivatives with improved efficacy and reduced toxicity compared to existing treatments. Also utilized in catalytic applications for organic transformations, particularly in asymmetric synthesis where the chelating diamine ligand enhances stereoselectivity.